Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Smith Nephew ADR Representing 2 Ord Shs C.SNN


Primary Symbol: SNN

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.


NYSE:SNN - Post by User

Post by thetis88on Jan 24, 2019 6:31pm
289 Views
Post# 29278484

Out of money experiences

Out of money experiencesBenedictus, you could be right and  Sunniva’s new cash could last past
May. But, it’s very hard to see in my humble opinion ,Sunniva not being taken over by the owners
of the California building, sometime in the early summerr of 2019, when they will 
be down to what  me thinks is their last cent.


What really bugs me is the statement by the CFO on the conference 
call that that they were going through .5 million in cash a month, which as you say 
was complete BS. My guess is that some investors
believed that statement, and bought  their stock on it. Also, the analysts on that
call never challenged that statement.

Also,, you are right that the debenture deal is far better for investors 
with  management participating , but It could be
that in order to  sell these debentures, Managemnt participation was
required. I don’t  known of course, but,I didn’t see insiders jump in and buy when the
stock was down to 2 dollars, whereas non management investor groups
were screaming it was the buy of a life time .

Last, we should have a contest.

It’s been about three weeks since  the first press release on future sales of Sunniva
Branded Products was put  out. It says on Jan 4 th , if I am reading It correctly, that delivery 
and sales commenced this week for  flower .I find both of these press 
releases very confusing.,but they did do their work, and jazzed up the stock price,

The contest would be simply who can be the first 
to identify the retail store, the product, and the price of a Sunniva 
Branded Product in California sold by a retail store. We 
There must be hundreds of California investors in the Discord group,
so I would expect them to win this easily.
As the press release seemed to say, sales started week of Jan 4 2019
so it must be an easy find.





<< Previous
Bullboard Posts
Next >>